Amdocs Ownership

DOX Stock  USD 88.31  0.31  0.35%   
The majority of Amdocs outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amdocs to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amdocs. Please pay attention to any change in the institutional holdings of Amdocs as this could imply that something significant has changed or is about to change at the company.
 
Shares in Circulation  
First Issued
1997-12-31
Previous Quarter
115.5 M
Current Value
113.4 M
Avarage Shares Outstanding
176.3 M
Quarterly Volatility
38.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Amdocs in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Amdocs, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Amdocs Stock Ownership Analysis

About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Amdocs was currently reported as 30.89. The company has Price/Earnings To Growth (PEG) ratio of 1.16. Amdocs last dividend was issued on the 31st of March 2025. The entity had 1:4 split on the December 1, 2003. Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. To learn more about Amdocs call Joshua Sheffer at 314 212 7000 or check out https://www.amdocs.com.
Besides selling stocks to institutional investors, Amdocs also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Amdocs' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Amdocs' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Amdocs Quarterly Liabilities And Stockholders Equity

6.29 Billion

Less than 1% of Amdocs are currently held by insiders. Unlike Amdocs' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Amdocs' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Amdocs' insider trades

Amdocs Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Amdocs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amdocs backward and forwards among themselves. Amdocs' institutional investor refers to the entity that pools money to purchase Amdocs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Dimensional Fund Advisors, Inc.2024-12-31
1.9 M
American Century Companies Inc2024-12-31
1.8 M
Pacer Advisors, Inc.2024-12-31
1.8 M
Morgan Stanley - Brokerage Accounts2024-12-31
1.7 M
Alyeska Investment Group, L.p.2024-12-31
1.7 M
Geode Capital Management, Llc2024-12-31
1.7 M
Nordea Investment Mgmt Bank Demark A/s2024-12-31
1.7 M
State Street Corp2024-12-31
1.4 M
Stifel Financial Corp2024-12-31
M
Fmr Inc2024-12-31
16.9 M
Pzena Investment Management, Llc2024-12-31
6.6 M
Note, although Amdocs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Amdocs Outstanding Bonds

Amdocs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amdocs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amdocs bonds can be classified according to their maturity, which is the date when Amdocs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Amdocs Corporate Filings

6K
18th of February 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
14th of February 2025
Other Reports
ViewVerify
17th of December 2024
Other Reports
ViewVerify
21st of October 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.